124 related articles for article (PubMed ID: 6194881)
21. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
22. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
Morton RF; Creagan ET; Veeder MH; Elson DL; Laurie JA; Nelimark RA; Chang MN
Cancer Treat Rep; 1987 Apr; 71(4):429-30. PubMed ID: 3548962
[No Abstract] [Full Text] [Related]
23. Combination chemotherapy of metastatic melanoma.
Berd D; Mastrangelo MJ
J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
[No Abstract] [Full Text] [Related]
24. Systemic chemotherapy in the treatment of malignant melanoma.
Lens MB; Eisen TG
Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
[TBL] [Abstract][Full Text] [Related]
26. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
[No Abstract] [Full Text] [Related]
27. [Marked regression of melanoma metastases under combined chemotherapy].
Klemm-Mayer H; Rasokat H; Wagner G
Z Hautkr; 1984 Apr; 59(7):443-5. PubMed ID: 6730608
[TBL] [Abstract][Full Text] [Related]
28. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
29. Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.
Jelić S; Babovic N; Kovcin V; Milicevic N; Milanovic N; Popov I; Radosavljevic D
Melanoma Res; 2002 Feb; 12(1):91-8. PubMed ID: 11828263
[TBL] [Abstract][Full Text] [Related]
30. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
Thompson JA; Gold PJ; Fefer A
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
[TBL] [Abstract][Full Text] [Related]
31. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Maeda K; Miura S; Kawamura M; Jimbow K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
[TBL] [Abstract][Full Text] [Related]
32. Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Long HJ; Green SJ
Med Pediatr Oncol; 1986; 14(2):86-7. PubMed ID: 3713642
[TBL] [Abstract][Full Text] [Related]
33. DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.
Hill GJ; Metter GE; Krementz ET; Fletcher WS; Golomb FM; Ramirez G; Grage TB; Moss SE
Cancer Treat Rep; 1979; 63(11-12):1989-92. PubMed ID: 393384
[No Abstract] [Full Text] [Related]
34. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
35. [Primary malignant melanoma of the female urethra: a case report].
Kajikawa H; Takada M; Seguchi T; Sakaguchi H
Hinyokika Kiyo; 1987 Jan; 33(1):97-100. PubMed ID: 2437781
[TBL] [Abstract][Full Text] [Related]
36. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
37. Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis.
Umeda M; Komatsubara H; Shigeta T; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):51-7. PubMed ID: 18504155
[TBL] [Abstract][Full Text] [Related]
38. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
Reinhold U; Bruske T; Kreysel HW
Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
[No Abstract] [Full Text] [Related]
39. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
40. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
